WuXi AppTec Co., Ltd.'s (SHSE:603259) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
WuXi AppTec Co., Ltd.'s (SHSE:603259) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
WuXi AppTec (SHSE:603259) has had a great run on the share market with its stock up by a significant 38% over the last three months. Since the market usually pay for a company's long-term fundamentals, we decided to study the company's key performance indicators to see if they could be influencing the market. In this article, we decided to focus on WuXi AppTec's ROE.
药明康德(SHSE:603259)在股票市场上的表现非常出色,过去三个月其股票上涨了显著的38%。由于市场通常关注公司的长期基本面,我们决定研究公司的关键绩效因子,以看看它们是否可能影响市场。 在这篇文章中,我们决定重点关注药明康德的ROE。
Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Simply put, it is used to assess the profitability of a company in relation to its equity capital.
净资产回报率或ROE是评估公司管理层如何有效利用公司资本的关键指标。简单来说,它用于评估公司相对于其股本的盈利能力。
How Do You Calculate Return On Equity?
如何计算股本回报率?
ROE can be calculated by using the formula:
ROE可以通过以下公式计算:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
股东权益回报率 = 净利润(来自持续运营)÷ 股东权益
So, based on the above formula, the ROE for WuXi AppTec is:
因此,根据上述公式,药明康德的ROE为:
15% = CN¥8.2b ÷ CN¥56b (Based on the trailing twelve months to September 2024).
15% = CN¥82亿 ÷ CN¥560亿(基于截至2024年9月的过去十二个月)。
The 'return' is the amount earned after tax over the last twelve months. One way to conceptualize this is that for each CN¥1 of shareholders' capital it has, the company made CN¥0.15 in profit.
“回报”是过去十二个月税后赚取的金额。一种概念化的方式是,对于每1元股东资本,公司赚取了0.15元的利润。
Why Is ROE Important For Earnings Growth?
ROE为什么对净利润增长很重要?
We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Based on how much of its profits the company chooses to reinvest or "retain", we are then able to evaluate a company's future ability to generate profits. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.
我们已经确定,ROE作为公司未来盈利的有效盈利生成指标。根据公司选择再投资或 "保留 "其利润的多少,我们能够评估公司未来产生利润的能力。一般而言,其他条件相同,具有高股本回报率和利润保留的公司,其增长率高于没有这些特征的公司。
WuXi AppTec's Earnings Growth And 15% ROE
药明康德的收益增长和15%的ROE
To begin with, WuXi AppTec seems to have a respectable ROE. Especially when compared to the industry average of 6.1% the company's ROE looks pretty impressive. Probably as a result of this, WuXi AppTec was able to see an impressive net income growth of 31% over the last five years. We reckon that there could also be other factors at play here. Such as - high earnings retention or an efficient management in place.
首先,药明康德的ROE相当可观。特别是与行业平均水平6.1%相比,该公司的ROE看起来相当令人印象深刻。可能由于这个原因,药明康德在过去五年中实现了31%的净利润增长。我们认为这里可能还有其他因素在起作用,比如高收益留存或高效的管理。
As a next step, we compared WuXi AppTec's net income growth with the industry, and pleasingly, we found that the growth seen by the company is higher than the average industry growth of 17%.
作为下一步,我们将药明康德的净利润增长与行业进行了比较,令人高兴的是,我们发现该公司的增长高于行业平均增长17%。
Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. What is 603259 worth today? The intrinsic value infographic in our free research report helps visualize whether 603259 is currently mispriced by the market.
盈利增长是评估股票时需要考虑的重要指标。投资者应该尝试判断预期的盈利增长或下降,无论是哪种情况,是否已经被市场定价。这样可以帮助他们判断该股票的未来是光明还是黯淡。那么603259今天值多少钱?我们免费研究报告中的内在价值信息图有助于可视化603259是否被市场错误定价。
Is WuXi AppTec Efficiently Re-investing Its Profits?
药明康德是否在有效地再投资其利润?
WuXi AppTec's three-year median payout ratio is a pretty moderate 29%, meaning the company retains 71% of its income. By the looks of it, the dividend is well covered and WuXi AppTec is reinvesting its profits efficiently as evidenced by its exceptional growth which we discussed above.
药明康德的三年中位数分红比例为29%,相对较为适中,这意味着公司留存71%的收入。从表面上看,分红覆盖良好,药明康德有效地再投资其利润,这从我们上述讨论的卓越增长中可以看出。
Moreover, WuXi AppTec is determined to keep sharing its profits with shareholders which we infer from its long history of five years of paying a dividend. Upon studying the latest analysts' consensus data, we found that the company is expected to keep paying out approximately 30% of its profits over the next three years. As a result, WuXi AppTec's ROE is not expected to change by much either, which we inferred from the analyst estimate of 16% for future ROE.
此外,药明康德决心继续与股东分享其利润,这可以从其长达五年的分红历史中推断得出。通过研究最新的分析师共识数据,我们发现预计公司将在未来三年内支付约30%的利润。因此,药明康德的ROE预计也不会有太大变化,这从分析师对未来ROE的16%的预测中可以推断得出。
Summary
总结
On the whole, we feel that WuXi AppTec's performance has been quite good. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. That being so, a study of the latest analyst forecasts show that the company is expected to see a slowdown in its future earnings growth. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.
总体而言,我们认为药明康德的表现相当不错。特别是,看到公司对其业务进行了大量投资,并且有高回报率,这导致其收益有了显著增长,这是很好的。尽管如此,最新的分析师预测研究表明,预计公司未来的收益增长将放缓。要了解更多关于该公司的最新分析师预测,请查看这张公司分析师预测的可视化图。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?对内容有疑虑?请直接与我们联系。或者,发送电子邮件至 editorial-team (at) simplywallst.com。
这篇来自Simply Wall St的文章是一般性的。我们根据历史数据和分析师预测提供评论,采用无偏见的方法,我们的文章并不旨在提供财务建议。它不构成对任何股票的买入或卖出建议,也未考虑到您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均没有持仓。